TEC
ALSN icon

Tiger Eye Capital’s Allison Transmission ALSN Stock Holding History

Tiger Eye Capital’s Portfolio ALSN Stock Details ALSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-115,081
Closed -$3.45M – 48
2014
Q1 		$3.45M Buy
+115,081
New +$3.33M 0.51% 36

Other funds holding ALSN

VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
GCM
Gates Capital Management New York $3.66B AUM 12.63% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return
CGI
CI Global Investments Oakland, California $6.5B AUM 8.71% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Tiger Eye Capital's ALSN Position: Q2 2014 in Review

Tiger Eye Capital sold out of Allison Transmission (ALSN) in Q2 2014, closing a stake of 115,081 shares — an estimated $3.45M sold.

Tiger Eye Capital first reported a position in ALSN in Q1 2014 and held it in 1 quarter. The position peaked at $3.45M in Q1 2014. 224 funds tracked by Wall St. Rank hold ALSN as of Q2 2014.

  • Tiger Eye Capital reported no remaining Allison Transmission position as of Q2 2014 after selling out during the quarter.
  • Tiger Eye Capital sold 115,081 Allison Transmission shares in Q2 2014, an estimated $3.45M.
  • Tiger Eye Capital first reported a position in Allison Transmission in Q1 2014 and held it in 1 quarter.
  • Tiger Eye Capital's Allison Transmission position peaked at $3.45M in Q1 2014.
  • 224 funds tracked by Wall St. Rank held Allison Transmission as of Q2 2014.

Based on Tiger Eye Capital's 13F filing for Q2 2014, filed 14 Aug 2014.